Skip to content

Prevalence and Impact on Quality of Life, Academic Performance, and Blood Indices of Heavy Menstrual Bleeding Among Female Students in Assiut University, Egypt

Prevalence and Impact of Heavy Menstrual Bleeding Among Female Students in Assiut University, Egypt

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07188259
Acronym
menorrhagia
Enrollment
340
Registered
2025-09-23
Start date
2025-11-30
Completion date
2027-06-30
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia

Brief summary

The cause of menstrual disorders is unknown because many female students, embarrassed or unsure of what is normal, never seek care. In young females, abnormal uterine bleeding is usually functional-reflecting immaturity or dysregulation of the hypothalamic-pituitary-ovarian axis, anovulatory cycles, or inherited bleeding disorders-while serious structural pathology is rare. Nevertheless, early bleeding can be the first sign of conditions such as polycystic-ovary syndrome, endometriosis, or von Willebrand disease. It is the primary source of iron-deficiency anemia in females before marriage, leading to chronic fatigue, diminished academic performance, and lower exam results. A sectional study will be performed using a semi-structured questionnaire to assess the presence of HMB using the SAMANTA scale after its Arabic validation, and also evaluate the effect of HMB on quality of life using the validated heavy menstrual bleeding scale and assess impact on academic performance finally both females with positive HMB or not will asked to do Complete blood count (CBC), serum ferritin and coagulation profile.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

1- Female students of Assiut University.

Exclusion criteria

1. Females known to have chronic anemia or hemolytic anemia by history 2. Females on anticoagulation treatment. 3. Females known to have coagulopathy. 4. Females with any chronic condition (diabetes mellitus, liver diseases, etc.) in the previous 12 months were excluded from participation in this study. 5. Females with a history of prior pregnancy (gravidity ≥1), regardless of outcome (live birth, miscarriage, abortion, or ectopic).

Design outcomes

Primary

MeasureTime frameDescription
the prevalence of heavy menstrual bleeding (HMB)through study completion, an average of 6 months to 1 year.to estimate the prevalence of heavy menstrual bleeding (HMB) among Assiut university female students.

Secondary

MeasureTime frameDescription
impact of heavy menstrual bleeding (HMB) on participants' quality of life and academic performance.through study completion, an average of 6 months to 1 yearTo evaluate the impact of heavy menstrual bleeding (HMB) on participants' quality of life and academic performance.
Hematologic (CBC indices, serum ferritin and coagulation profile) between participantswithin 2 months after questionnaireCompare hematologic (CBC indices, serum ferritin and coagulation profile) between participants with HMB and partcipants without HMB.

Countries

Egypt

Contacts

Primary ContactYasmin I.Mohamed
Yasmin.20134496@med.aun.edu.eg01150883767
Backup ContactAmany Heshmat Abdelmoneam
Dramany9@med.aun.edu.eg01008725338

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026